Invited letter concerning: Fibrinogen receptor antagonists in cardiopulmonary bypass
Open Access
- 28 November 1993
- journal article
- other
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 106 (5) , 931-933
- https://doi.org/10.1016/s0022-5223(19)34050-4
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Development of GPIIb/IIIa antagonists as antithrombotic drugsTrends in Pharmacological Sciences, 1992
- Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitorsJournal of Medicinal Chemistry, 1992
- Cyclic RGD peptide analogs as antiplatelet antithromboticsJournal of Medicinal Chemistry, 1992
- Three-dimensional structure of echistatin, the smallest active RGD proteinBiochemistry, 1991
- Identification of the disulfide bond pattern in albolabrin, an RGD-containing peptide from the venon of trimeresurus albolabris: Significance for the express of platelet aggregation inhibitory activityBiochemistry, 1991
- Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.Circulation, 1989
- Quantitation of platelet preservation with prostanoids during simulated bypassJournal of Surgical Research, 1987
- Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.Journal of Clinical Investigation, 1986
- Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the .gamma. chainBiochemistry, 1984
- Preservation of human platelets with prostaglandin E1 during in vitro simulation of cardiopulmonary bypass.Circulation Research, 1979